News from the FDA/CDC
News from the FDA/CDC
Immunocompromised patients should receive fourth COVID shot: CDC
The CDC contacted pharmacies on Jan. 26 to reinforce the message that people with moderate to severe immune suppression should receive a fourth...
News from the FDA/CDC
FDA approves risankizumab (Skyrizi) for psoriatic arthritis
The approval is the second indication for the anti–interleukin-23 monoclonal antibody after clearance for plaque psoriasis was granted in 2019.
News from the FDA/CDC
FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitis
“It’s big news because a few years ago we didn’t have any systemic treatments that are safer than the classical immunosuppressants.”
News from the FDA/CDC
ACIP releases new dengue vaccine recommendations
Puerto Rico is the main focus of control efforts because 95% of U.S. dengue cases originate there.
News from the FDA/CDC
CDC to update mask recommendations as Omicron spreads
“The best mask that you wear is the one you will wear and the one you can keep on all day long,” said Dr. Rochelle Walensky.
News from the FDA/CDC
FDA OKs new adult insomnia med
Whereas the overall results are very positive, the improvements in daytime functioning are especially “exciting.”
News from the FDA/CDC
CDC defends new COVID guidance as doctors raise concerns
“The new recommendations on quarantine and isolation are not only confusing, but are risking further spread of the virus.”
News from the FDA/CDC
COVID-19–positive or exposed? What to do next
News from the FDA/CDC
COVID-19 antigen tests may be less sensitive to Omicron: FDA
News from the FDA/CDC
FDA gives nod to tralokinumab for adults with moderate to severe AD
The drug is expected to be available by February 2022.
News from the FDA/CDC
FDA authorizes Pfizer antiviral pill for COVID-19